Novartis Gene Therapies

Novartis Gene Therapies, formerly AveXis and a Bausch + Lomb company, is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases..

Year Established: 2010 Stock Ticker: NVS Exchange: NYSE

Locations